Placebo News and Research RSS Feed - Placebo News and Research

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Researchers at the University of Southampton are to study the use of Chinese Herbal Medicines in treating recurrent urinary tract infections (RUTIs), in the first clinical trial of its kind in the UK. [More]
Transplanted human stool may offer treatment hope for ulcerative colitis patients

Transplanted human stool may offer treatment hope for ulcerative colitis patients

Patients with ulcerative colitis (UC) may improve their symptoms with a transplantation of healthy stool from donors, according to Australian researchers. The findings were presented by Dr Sudarchan Paramsothy MD, a gastroenterologist from the University of New South Wales, Australia at the Digestive Disease Week conference in San Diego, California between the 21st to 24th May. [More]
Early aspirin benefits after minor stroke 'underestimated'

Early aspirin benefits after minor stroke 'underestimated'

A meta-analysis of individual patient data has thrown light on the benefits of aspirin for secondary prevention in patients with ischaemic stroke. [More]
SUSTAIN study to test effect of high-dose selenium on recovery of cardiac surgery patients

SUSTAIN study to test effect of high-dose selenium on recovery of cardiac surgery patients

Queen's University researcher Daren Heyland is leading a study that aims to reduce the risk of complications and improves recovery of cardiac surgery patients. [More]
High doses of vitamin D supplements could lead to fewer birth complications but reduce fertility

High doses of vitamin D supplements could lead to fewer birth complications but reduce fertility

New research has established that high doses of vitamin D supplements can lead to fewer complications during childbirth but reduce a woman's chances of getting pregnant in the first place. [More]
Early high-dose rhEPO fails to improve neurodevelopment in very preterm infants

Early high-dose rhEPO fails to improve neurodevelopment in very preterm infants

Very preterm infants do not gain protection against neurodevelopmental delay with early prophylactic high-dose recombinant human erythropoietin, researchers report. [More]
Melatonin can be of great value for elderly people suffering from hypertension

Melatonin can be of great value for elderly people suffering from hypertension

The older we get, the more likely our circadian rhythms are disrupted. For example, blood pressure (BP), not only tends to increase but as well become more irregular. Luckily, as we show in our research, melatonin helps to ameliorate both trends. [More]
Smokers who use novel nicotine inhaler twice as likely to quit smoking

Smokers who use novel nicotine inhaler twice as likely to quit smoking

A study by researchers at New Zealand's University of Otago, Wellington shows that smokers who used a nicotine inhaler were twice as likely to quit smoking as smokers using a placebo inhaler. [More]
Magic mushroom compound may offer potential new way for antidepressant research

Magic mushroom compound may offer potential new way for antidepressant research

Psilocybin – a hallucinogenic compound derived from magic mushrooms – may offer a possible new avenue for antidepressant research, according to a new study published in The Lancet Psychiatry today. [More]
Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea. [More]
Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

New analyses presented at the American Thoracic Society’s 2016 annual conference (ATS 2016) further add to the efficacy and safety profile of OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF). [More]
Clinical study shows sitagliptin drug not effective in treating NAFLD

Clinical study shows sitagliptin drug not effective in treating NAFLD

A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia. [More]
Combination of two compounds found in red grapes, oranges could treat diseases

Combination of two compounds found in red grapes, oranges could treat diseases

A combination of two compounds found in red grapes and oranges could be used to improve the health of people with diabetes, and reduce cases of obesity and heart disease. [More]
Psychological therapies may help people who self-harm, study finds

Psychological therapies may help people who self-harm, study finds

Latest research out today has found that psychological therapies, more commonly known as ‘talking treatments’, may help people who self- harm. [More]
Could oral supplements affect teenage behavior? An interview with Prof. Stein and Dr Tammam

Could oral supplements affect teenage behavior? An interview with Prof. Stein and Dr Tammam

We wanted to see whether supplementing the diet of disadvantaged adolescents with the omega 3 polyunsaturated acids, EPA & DHA, vitamins and minerals over a school term might improve their antisocial behaviour, which usually gets worse during a term. [More]
Repeat, low-dose ketamine infusions may quickly reduce suicidal thoughts in depressed outpatients

Repeat, low-dose ketamine infusions may quickly reduce suicidal thoughts in depressed outpatients

Repeat intravenous treatment with low doses of the anesthetic drug ketamine quickly reduced suicidal thoughts in a small group of patients with treatment-resistant depression. [More]
Transcranial direct current stimulation proves effective for binge-eating disorder

Transcranial direct current stimulation proves effective for binge-eating disorder

Transcranial direct current stimulation, or tDCS, has proved effective for binge-eating disorder for the first time, according to researchers at the University of Alabama at Birmingham. [More]
More evidence for combination therapy benefits in PAH

More evidence for combination therapy benefits in PAH

Another meta-analysis adds to evidence of increased benefits for patients with pulmonary arterial hypertension who are given combination therapy. [More]
UA researchers one step closer to preventing asthma in children

UA researchers one step closer to preventing asthma in children

Efforts to improve the health of children at increased risk for asthma will receive a major boost with the launch of a new University of Arizona Health Sciences-led, federally funded national clinical study. For Fernando D. Martinez, MD, and his colleagues at the UA Asthma and Airway Disease Research Center, this study follows 30 years of research to prevent and cure this chronic disease. [More]
Caution urged with add-on DPP-4 inhibitors

Caution urged with add-on DPP-4 inhibitors

Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis. [More]
Advertisement
Advertisement